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The detection of lead in fetal tissues by chemical analysis has long been accepted
as prima facie evidence for the permeability of the placenta to this nonessential
trace metal. However, only a few investigations, all on lower mammalian species, have
contributed any direct experimental data bearing on this physiological process. Recent
radioactive tracer and radioautographic studies on rodents have shown that lead crosses
the placental membranes rapidly and in significant amounts even at relatively low ma-
ternal blood levels. While it is not possible to extrapolate directly the results of these
experiments to humans because of differences in placental structure and other factors,
the results do serve as a warning of the possible hazard to the human embryo and
fetus of even low levels of lead in the maternal system.
The transfer of lead across the human
placenta and its potential threat to the con-
ceptus have been recognized for well over
a century. Abundant early evidence of this
hazard came from reports that women
working in lead industries commonly exhi-
bited unusually high rates of sterility, spon-
taneous abortion, and stillbirths (1-3). Even
before the industrial lead hazard to preg-
nancy was accepted and acted upon, how-
ever, lead compounds were known for their
embryotoxic properties and were often used
in attempts at criminal abortion (4). More
reliable evidence for the permeability of the
human placenta to lead began to appear in
the 1930's, when chemical analytical techni-
ques for detecting lead in blood and other
tissues were developed. The early studies of
Kehoe et al. (5) and of Thompsett and An-
derson (6), although limited to small series
and restricted ranges of gestational ages,
clearly demonstrated the presence of lead in
fetal tissues and left little doubt that the
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human placenta was permeable to this toxic
trace metal.
A more recent study by Barltrop (7) util-
izing refined analytical methods, larger and
better controlled series of subjects, and the
technique of paired sampling of maternal
blood with fetal blood and tissue has given
us a much better appreciation of the extent
of lead transfer to the human fetus during
gestation and the distribution of lead in fe-
tal tissues. This study, which was conducted
on apparently normal humans, indicated
that placental transfer of lead began as early
as the 12th week of gestation and that the
total lead content in fetal tissues increased
throughout pregnancy. A typical adult dis-
tribution of lead was found in fetuses with
highest concentrations in bone and liver but
significant amounts also in the blood, pla-
centa, brain, heart, and kidney. The total
amount of lead transferred during preg-
nancy appeared to be relatively small,
amounting to less than 300 Ag, approxi-
mately the amount of lead ingested by an
average adult per day. However, as pointed
out by Barltrop, the location of lead within
the fetus at different stages of gestation is
probably of far greater importance than the
total amount present at term.
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that of Barltrop, have shown that the level
of lead in human umbilical cord blood, taken
at delivery, ranges from 10 to 90 pLg/100 g
with an average of about 13 jug/100 g (8-11).
An interesting aspect of these data was that
in nearly all paired blood samples, cord blood
levels were slightly lower than those of ma-
ternal blood. This observation has prompted
speculation that fetal tissues might remove
lead from blood more efficiently than mater-
nal tissues (7).
In searching the literature for comparative
data, one finds there have been rela-
tively few experimental studies on the pla-
cental permeability of lead in lower mam-
mals. Baumann (12) in 1933, was the first
to demonstrate experimentally the placental
transfer of lead in a mammal. She injected
pregnant rats with very small doses (0.01 ug)
of radioactive lead (212Pb, Thorium B)
and followed its distribution in the
mother and fetus by whole body radio-auto-
graphy. Although the methodology was prim-
itive in comparison with that available today
and the series of animals small, neverthe-
less, her results indicated that lead rapidly
crossed the placenta (within 1 1/2 hr
after injection) and localized within the fe-
tal tissues, primarily developing bone.
Other early studies in which lead was de-
tected by' chemical analysis in the fetuses
and newborns of lead-treated rats (13,14)
and dogs (15) confirmed the general perme-
ability of the mammalian placenta to this
element.
Further experimentation on the placental
permeability of lead apparently lapsed until
1970, when McClain and Becker (16) re-
ported briefly on the placental transport and
teratogenicity of inorganic lead in rats and
mice. In this study, 50 mg/kg of radioactive
lead nitrate (210Pb) was infused intraven-
ously at a rate of 0.5 mg/kg-min into preg-
nant rats and mice during late gestation.
Lead was found to cross the placenta to a
limited extent during this period, homogen-
ized fetuses containing between 0.02 and
0.30/ig/ml 6 hr after a single administration.
In 1972, the same workers (17) conducted
further experiments on rats to determine
the placental permeability and teratogeni-
city of several organolead compounds
(tetraethyllead, tetramethyllead, and tri-
methyllead chloride). Infusion studies with
trimethyllead chloride during the late stages
of gestation (day 20 of the 21-day gestation
cycle) indicated that the rate of placental
transfer was minimal when blood concentra-
tions were below what they considered to be a
saturation point for binding sites on mater-
nal erythrocytes ( -.400 Mg/ml whole blood)
and was greatly increased at maternal blood
concentrations above this saturation point.
The only available experimental data on
the placental transfer of lead during the ter-
atogenically critical early periods of gesta-
tion come from a recent autoradiographic
study by Carpenter et al. (18). In this study
pregnant golden hamsters were injected in-
travenously on day 7 or 8 of their 16-day
gestation cycle with 20 or 50 uCi/kg body
weight of lead 210Pb nitrate (the equivalent
of 2.4 and 6.1 ug Pb/kg respectively). Auto-
radiographs of gestation sacs recovered as
early as 15 min postinjection revealed ex-
tensive a-track labeling of the yolk sac pla-
cental membranes, the amnion, and the em-
bryo proper. Highest levels of radioactivity
in these regions occurred, however, between
1 and 4 hr postinjection. The results of this
study showed that (1) during early gesta-
tion inorganic lead crosses the placental
membranes rapidly and in significant
amounts, even at very low maternal blood
levels, and (2) that in this species the yolk
sac placenta rather than the developing
chorioallantoic placenta is the primary trans-
fer site for lead. In addition, the general-
ized distribution of radioactivity observed in
the embryos indicated that all major organ
systems are exposed to lead ions during this
very critical period of development.
In summing up, it is clear that while we
now have a substantial body of indirect evi-
dence for the permeability of the placenta
to lead from studies on human subjects, only
a few investigations, all on lower mammal-
ian species, have contributed any basic ex-
perimental data bearing on the physiological
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of course, due to differences in placental
structure and other factors, to extrapolate
directly to humans placental permeability
data obtained from experiments on lower
mammals. Nevertheless, previous experience
with many substances has shown that such
data often provide a good indication of the
human response. Given the difficulties and
risks inherent in experimenting with toxic
substances in humans, experimental animals
such as the rodents and, perhaps in the fu-
ture, other mammalian species phylogenet-
ically closer to humans, will continue to be
our major source of experimental data on the
placental permeability and reproductive haz-
ards of lead. In view of the increasing levels
of accessible lead in our present day environ-
ment the need for more such basic research
in these areas is clearly indicated. In partic-
ular, it is important that we obtain soon
more information on the rate of placental
transfer of lead and its relation to gestational
age, maternal blood lead levels, the trans-
fer of other cations, such as calcium and
zinc, and to other physiological and environ-
mental factors known to influence lead toxi-
city (19). Further research directed toward
determining the actual cellular mechanisms
of placental lead transfer would also be de-
sirable. Finally, it is imperative that we
learn more about the amount and distribu-
tion of lead reaching the embryo and fetus
at different stages of gestation and the con-
sequent acute and long-term pathological ef-
fects of this exposure.
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